These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21995337)

  • 1. Medicare drug prices and the deficit.
    Frank RG
    N Engl J Med; 2011 Nov; 365(18):1657-9. PubMed ID: 21995337
    [No Abstract]   [Full Text] [Related]  

  • 2. Managed care payments, drug prices ripe for savings efforts.
    Med Health; 2005 Oct; 59(37):2, 7. PubMed ID: 16250202
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 4. Health and Taxes.
    Cutler DM
    JAMA; 2016 Oct; 316(16):1634-1635. PubMed ID: 27784083
    [No Abstract]   [Full Text] [Related]  

  • 5. The war on drug--prices: states are taking up the fight to reduce prescription drug costs.
    Boulard G
    State Legis; 2002 Mar; 28(3):12-7. PubMed ID: 11873811
    [No Abstract]   [Full Text] [Related]  

  • 6. Help your patients become aware of the new medicare prescription drug plans.
    McClellan M
    Oncologist; 2005 Sep; 10(8):563-4. PubMed ID: 16177280
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis & commentary. Health care reform is likely to widen federal budget deficits, not reduce them.
    Holtz-Eakin D; Ramlet MJ
    Health Aff (Millwood); 2010 Jun; 29(6):1136-41. PubMed ID: 20530343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing generic drug use in Medicare Part D: the role of government.
    Kohl H; Shrank WH
    J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
    Latham SR
    J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
    [No Abstract]   [Full Text] [Related]  

  • 11. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 12. Slouching toward the Medicare fix.
    Solomon B
    Natl J (Wash); 1997 Feb; 29(5):235. PubMed ID: 10164808
    [No Abstract]   [Full Text] [Related]  

  • 13. US government debates Medicare coverage of prescription costs.
    Gottlieb S
    BMJ; 1999 Jul; 319(7202):75. PubMed ID: 10398616
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation.
    Conti RM; Rosenthal MB
    N Engl J Med; 2016 Feb; 374(8):703-6. PubMed ID: 26933845
    [No Abstract]   [Full Text] [Related]  

  • 16. Savings from drug discount cards: relief for Medicare beneficiaries?
    Cubanski J; Frank RG; Epstein AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opinion: The high cost of low drug prices.
    Franks B
    N J Med; 2004; 101(7-8):56, 55. PubMed ID: 15373148
    [No Abstract]   [Full Text] [Related]  

  • 18. How can states provide affordable pharmaceuticals to the underserved?
    Zara J
    J Health Care Poor Underserved; 2006 Nov; 17(4):808-20. PubMed ID: 17242532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare and drug pricing.
    Iglehart JK
    N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: cost savings.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-20. PubMed ID: 19297717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.